SEC Comment Letter for AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Jan 8, 2007

AGENUS INC (AGEN) (CIK 0001098972)
Date: Jan. 8, 2007 · CIK: 0001098972 · Accession: 0000000000-07-000773

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

January 8, 2007

Author

Kevin Woody

Form

UPLOAD

Company

AGENUS INC (AGEN) (CIK 0001098972)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 January 8, 2007 Garo H. Armen, Ph.D. Chief Executive Officer and Chairman of the Board Antigenics Inc. 630 Fifth Avenue Suite 2100 New York, NY 10111

Re: Antigenics Inc. Form 10-K for Fiscal Year Ended December 31, 2005 File No. 0-29089

Dear Dr. Armen:

We have completed our review of your Form 10-K and have no further comments at this time.

S i n c e r e l y ,

Kevin Woody B r a n c h C h i e f

Show Raw Text

Via Facsimile and U.S. Mail
Mail Stop 6010
        January 8, 2007

Garo H. Armen, Ph.D.
Chief Executive Officer and Chairman of the Board
Antigenics Inc.
630 Fifth Avenue
Suite 2100
New York, NY  10111

Re: Antigenics Inc.
 Form 10-K for Fiscal Year Ended December 31, 2005
 File No. 0-29089

Dear Dr. Armen:

 We have completed our review of your Form 10-K and have no further comments
at this time.

        S i n c e r e l y ,

Kevin Woody
        B r a n c h  C h i e f

SecProbe.io